ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
93,191.14
-0.35%
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs Yen
157.8185
-0.04%
Brent Oil
73.795
0.23%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. カナダ
  5. TSX
  6. Oncolytics Biotech Inc (ONC)

  7. Oncolytics Biotech Inc (ONC) ニュース

ONC

Oncolytics Biotech (ONC)

Oncolytics Biotech Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:TSX:ONC
日付受信時刻ニュースソース見出しコード企業名
2023/09/2621 : 00PR Newswire (US)THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSTSX:ONCOncolytics Biotech Inc
2022/06/0201 : 23PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONC.WTTSX:ONCOncolytics Biotech Inc
2022/06/0201 : 21PR Newswire (Canada)IIROC Trading Halt - ONC.WTTSX:ONCOncolytics Biotech Inc
2022/01/1101 : 57PR Newswire (US)New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024TSX:ONCOncolytics Biotech Inc
2022/01/1101 : 54PR Newswire (US)New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024TSX:ONCOncolytics Biotech Inc
2021/04/1000 : 56PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
2021/04/1000 : 56PR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
2021/04/1000 : 53PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
2021/04/1000 : 52PR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
2021/02/1800 : 08PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
2021/02/1800 : 07PR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
2021/02/1723 : 58PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
2021/02/1723 : 56PR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2506 : 06PR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2504 : 00PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2503 : 48PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2503 : 47PR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2501 : 56PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2501 : 54PR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2501 : 41PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2501 : 39PR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2423 : 33PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2423 : 31PR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2423 : 28PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
2020/03/2423 : 26PR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
2017/12/2721 : 00PR Newswire (US)Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patien...TSX:ONCOncolytics Biotech Inc
2017/12/2721 : 00PR Newswire (Canada)Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patien...TSX:ONCOncolytics Biotech Inc
2017/12/0521 : 00PR Newswire (US)Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic B...TSX:ONCOncolytics Biotech Inc
2017/12/0521 : 00PR Newswire (Canada)Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic B...TSX:ONCOncolytics Biotech Inc
2017/12/0421 : 00PR Newswire (US)Oncolytics Biotech® to Present at the Oncolytic Virotherapy SummitTSX:ONCOncolytics Biotech Inc
 Showing the most relevant articles for your search:TSX:ONC

最近閲覧した銘柄

AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
NYSE
AXP
American Express
NYSE
KO
Coca Cola
CCOM
US30
US 30
FX
USDEUR
US Dollar vs Euro
CCOM
SILVER
SILVER
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
USI
USTECH100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
COIN
DOGEUSD
Dogecoin
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有